Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
emtricitabine (emtriva) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
COVID-19 convalescent plasma (1 trial)
Trials (2 total)
Trial APIs (3 total)